Eastman Chemical Company is reiterated as a 'Buy' with a fair value of $104/share and a price target of $84/share. EMN's operational improvements, including 2Q26 AEPS up 23% and EBIT up 16%, contrast with market pessimism and a depressed 7-8x P/E multiple. The investment thesis centers on cost savings, volume recovery, and molecular recycling, supporting normalized EPS potential of $8/share.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Evaluate Eastman Chemical's (EMN) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Eastman Chemical NYSE: EMN said it expects stronger earnings growth in the second half of 2026 than it anticipated in April, citing volume gains, improved asset utilization and price-cost benefits across its specialty businesses. During its second-quarter earnings call, Chief Executive Officer Mark Costa said the company is not forecasting a broad recovery in weak discretionary markets such as automotive, consumer durables and certain aftermarket categories.
Eastman's Q2 earnings and sales top estimates as higher volumes and pricing drive double-digit profit growth.
Eastman Chemical is rated a "Buy," leveraging its U.S.-centric assets amid Middle East disruptions and demonstrating resilient Q2 performance. EMN's Chemical Intermediates segment saw a 39% revenue surge, benefiting from supply shortages, while Advanced Materials and Fibers face demand headwinds. Free cash flow is pressured by working capital but expected to improve, with net debt projected under 3x and a secure 5% dividend yield.
Although the revenue and EPS for Eastman Chemical (EMN) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Eastman Chemical (EMN) came out with quarterly earnings of $1.97 per share, beating the Zacks Consensus Estimate of $1.8 per share. This compares to earnings of $1.6 per share a year ago.